The Coronavirus Disease 2019 (COVID-19) public health emergency has dramatically demonstrated the power of digital health technologies to transform the delivery of health care. Expanded telehealth and remote patient monitoring services, authorized by Congress and implemented by the Centers for Medicare & Medicaid Services a year ago, have provided millions of patients access to physician and other practitioner services during a pandemic when traditional modes of delivery of care would have brought great risk to patients and providers alike. At a time when digital health is defining a new future for the delivery of health care, the question arises - how will the Medicare program advance coverage and reimbursement for digital health technologies? Register now and join the conversation on Wednesday, March 10, 2021.
The experience during the past year with the benefits of expanding telehealth has demonstrated in very concrete ways, the critical role the Medicare statute and regulatory policies play in either providing access--or creating barriers--to the benefits of digital health technologies. This experience has also shown how Medicare, the nation’s single largest payer of health care services, can pave the way for changes in private health insurance, as they too have expanded coverage of these services.
This webinar will review recent changes to Medicare telehealth policies during the public health emergency and explore how expanded access to these services has transformed policymakers’ thinking about the continued benefits of telehealth once the public health emergency ends. These benefits have set the stage for a broader evaluation of the need to modernize the Medicare program to more explicitly address coverage and payment for digital health technologies. Drawing on the findings of the recently released AdvaMed-CapView report, Modernizing Medicare Coverage of Digital Health Technologies, the webinar will also explore ways Medicare’s regulatory policies currently create barriers to coverage and payment for digital health technologies, and how these policies can be changed, across the program’s major benefit categories, to accommodate coverage and payment—without having to change the Medicare statute.
Presenters for the webinar will include CapView Strategies and AdvaMed staff as well as a digital company:
- Richard Price, Senior Vice President, Payment and Health Care Delivery, AdvaMed
- Jen Rak, JD, MPH, Vice President, CapView Strategies
- Purva Rawal, PhD, Principal, CapView Strategies
- Lu Zawistowich, ScD, President and Founder, CapView Strategies
Richard Price is Senior Vice President in the Payment and Health Care Delivery Department of the Advanced Medical Technology Association (AdvaMed). In that role, he works on a variety of coverage and reimbursement issues, including health delivery reform models, Medicare’s inpatient prospective payment system, the Competitive Bidding Program for durable medical equipment, coverage of innovative diabetes technologies, and coverage of telehealth and other digital technologies.. Prior to joining AdvaMed, Mr. Price had a long career at the U.S. Congressional Research Service (CRS) where he served as the head of the Health Care and Medicine Section, directing research and working directly with top health committee staff to support the committees in their legislative responsibilities and priorities. Mr. Price received his M.A. from Johns Hopkins’ School of International Studies and his B.A. from the Johns Hopkins University.
Lu Zawistowich, ScD, is the President and Founder of CapView Strategies and is a nationally recognized thought-leader on Medicaid, Medicare, the Affordable Care Act (ACA), and health care innovation and reform. She advises clients on their strategic business and public policy objectives. Her work includes developing and implementing legislative and regulatory solutions on a broad range of issues, including Medicaid expansion and reform, Medicare restructuring, implementation of state health exchanges, drug and device coverage and payment, and health care financing.
Dr. Zawistowich has held numerous senior leadership positions during her distinguished career in both the public and private sectors. She served as the founding Executive Director of the Medicaid and CHIP Payment and Access Commission (MACPAC), which was launched under her leadership to be a trusted and credible resource for Congress, states, and key stakeholders on Medicaid and CHIP policy. She established the Commission’s policy analysis framework, its data development strategies, and its research agenda. She also secured Congressional funding for MACPAC—creating a long-term, stable financial foundation for the Commission.
Dr. Zawistowich previously served as the Acting Deputy Director of the Center for Consumer Information and Insurance Oversight (CCIIO) at the U.S. Department of Health and Human Services (HHS) and was instrumental in setting up this organization to implement the provisions of the ACA.
Dr. Zawistowich’s private sector experience includes serving as Senior Health Policy Advisor at Patton Boggs, LLP, where she developed and executed regulatory and legislative strategies for high-profile clients in Medicare, Medicaid, and private health insurance. As the Director of Reimbursement and Planning for Amgen, the world’s largest biotechnology company, Dr. Zawistowich worked with product brand teams on coverage and reimbursement strategies for FDA approved and marketed products, as well as for products in the pipeline. She also developed regulatory and legislative strategies to address the impact of the 2003 Medicare Modernization Act (MMA). As Deputy Executive Director of the Medicare Payment Advisory Commission (MedPAC), Dr. Zawistowich advised Congress on Medicare payment policies in fee-for-service and managed care, and on access to care and quality-of-care issues.
During her prior tenure at the Centers for Medicare and Medicaid Services (CMS), Dr. Zawistowich directed the Medicare demonstrations group, implemented the Medicare managed care risk adjustment payment system and the competitive bidding demonstration projects—the prototypes for the new Medicare competitive bidding models. She also managed operations in the Medicare fee-for-service program as the Director of the Contractor Management Group. During the Clinton Administration, she served as Director of the Office of State Health Reform and worked with states on broad-based health care reform initiatives and implemented Medicaid managed care programs. Dr. Zawistowich also served as Executive Director of the Competitive Pricing Advisory Committee and Deputy Director of Medicaid Policy. She started her career in public policy at the State of Maryland Department of Health and Mental Hygiene working on Medicaid program development and financing issues.
Dr. Zawistowich holds a ScD from The Johns Hopkins Bloomberg School of Public Health.
Jen Rak, JD, MPH, is Vice President at CapView where she works with health plans, life sciences companies, health systems, and think tanks, with particular expertise in payment, quality initiatives, and health care innovation and transformation issues. Jen previously was Director of Health Policy in Anthem’s Public Policy Institute where she led research work on Medicare, Commercial, and Health Care Exchange marketplace. There, she focused on payment policies and strengthening risk adjustment programs in these markets. She also led work examining issues in quality ratings programs, particularly the Medicare Advantage and Part D Star Ratings program. Prior to joining Anthem, Jen worked in the Division of Eligibility and Enrollment at the Center for Consumer Information and Insurance Oversight (CCIIO).
From 2010 until 2014, Jen was a consultant with Avalere Health, a health policy consulting firm, where she supported health plan and life science clients on health reform issues, especially related to Medicare Advantage and Part D. Jen has also worked on developing quantitative analyses and data models supporting a variety of strategic business initiatives for life science and health plans. Previously, Jen was an Executive Director in the Federal Programs Health Policy department at America’s Health Insurance Plans (AHIP). Jen is a certified patent attorney and worked as an associate in the law firm of Cooper & Dunham, LLC prosecuting biologic patent applications. Jen has a Juris Doctor degree from Case Western Reserve University School of Law, a Masters of Health Policy degree from the Rollins School of Public Health at Emory University, and a Bachelor of Arts degree from Reed College.
Purva Rawal, PhD, is a Principal at CapView where she works with health systems, life sciences companies, think tanks, and healthcare coalitions, with particular expertise in payment and delivery reform, and health system sustainability and transformation issues. She is also an Adjunct Assistant Professor at Georgetown University, where she teaches undergraduate classes including “Politics of Health Care”. Dr. Rawal has also recently completed a book examining the veracity of beliefs and claims about health reform, The Affordable Care Act: Explaining the Facts, due to be published in January 2016. She also serves on The Board of Trustees for the Woodley House, a mental health housing and support agency.
From 2005-2010 Dr. Rawal served as staff in the U.S. Senate where she worked on the Senate Budget Committee as a key advisor to Chairman Conrad (D-ND) during the drafting and passage of the Affordable Care Act (ACA). Prior to that, she was the health advisor to Sen. Joseph Lieberman (I-CT). After leaving Capitol Hill, Purva was a Director in the Health Insurance and Reform Practice at Avalere Health. She began her health policy career as a Christine Mirzayan Science and Technology Fellow at the National Academy of Sciences/Institute of Medicine, and began on Capitol Hill as a Congressional Fellow for the Society for Research on Child Development and the American Association for the Advancement of Science (AAAS). Dr. Rawal received her BA and PhD from Northwestern University.